Anika Therapeutics, Inc. Share Price & Technical Analysis
ANIK · $14.88 (-0.93%)
Healthcare / Drug Manufacturers - Specialty & Generic
$14.88
-0.93%
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opi…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
10% return in May, -6% avg return in past 3 year May month.
48% return in 2026, -29% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -4% | 57% | 1% | -15% | 10% | – | – | – | – | – | – | – | 48% |
| 25 | 3% | 4% | -14% | -3% | -23% | -4% | -22% | 15% | 1% | 4% | 1% | -2% | -41% |
| 24 | 4% | 3% | 5% | 2% | -2% | -1% | 7% | -6% | -3% | -30% | 3% | -6% | -25% |
| 23 | 4% | 3% | -9% | -11% | 5% | -4% | -10% | -23% | 3% | 5% | 13% | 4% | -20% |
| 22 | -13% | 2% | -23% | -14% | 1% | 1% | 4% | -3% | 6% | 18% | 10% | -7% | -17% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Uptrend
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation. It also provides Integrity, an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; non-orthopedic products, including Hyvisc, a high molecular weight injectable HA veterinary product for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine OA; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and ophthalmic products; and Anikavisc and Nuvisc high molecular weight HA products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$193.46M
P/E ratio
—
52W high
$16.24
52W low
$7.87
Volume
50,841
Beta
0.16
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Anika Therapeutics, Inc. share price today?
- Anika Therapeutics, Inc. (ANIK) last traded around $14.88 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ANIK have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ANIK. Download the app for real-time alerts.
- How can I analyze Anika Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.